André F Ciruelos EM, Rubovsky M, et al. Alpelisib (ALP) + fulvestrant (FUL) for advanced breast cancer (ABC): results of the Phase 3 SOLAR-1 trial. ESMO 2018, abstract LBA3_PR.
Trends in overleving bij uitgezaaid melanoom: analyse 2013-2021
apr 2024 | Dermato-oncologie